- Home
- SRPT vs INFQ Comparison
SRPT vs INFQ Comparison
Compare SRPT & INFQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRPT | INFQ |
|---|---|---|
| Founded | 1980 | 2007 |
| Country | United States | United States |
| Employees | N/A | 205 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.7B |
| IPO Year | 2000 | 2026 |
Fundamental Metrics
Financial Performance| Metric | SRPT | INFQ |
|---|---|---|
| Price | $17.12 | $11.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 29 | 1 |
| Target Price | ★ $25.85 | $20.00 |
| AVG Volume (30 Days) | 2.7M | ★ 8.2M |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.88 | N/A |
| Revenue | ★ $2,198,237,000.00 | N/A |
| Revenue This Year | N/A | $25.46 |
| Revenue Next Year | N/A | $25.00 |
| P/E Ratio | $5.78 | ★ N/A |
| Revenue Growth | ★ 15.58 | N/A |
| 52 Week Low | $10.42 | $8.52 |
| 52 Week High | $43.92 | $21.28 |
Technical Indicators
Market Signals| Indicator | SRPT | INFQ |
|---|---|---|
| Relative Strength Index (RSI) | 34.11 | 43.41 |
| Support Level | $16.09 | $8.54 |
| Resistance Level | $19.32 | $12.22 |
| Average True Range (ATR) | 1.14 | 1.16 |
| MACD | -0.48 | -0.26 |
| Stochastic Oscillator | 8.24 | 23.05 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
About INFQ Infleqtion Inc. Common Stock
Infleqtion Inc developing and commercializing quantum technology products as part of a full-stack platform, which currently includes offerings such as quantum sensing, quantum computing, and software. Its quantum-enabled solutions are focused on addressing the world's pressing challenges, with technologies actively deployed across some sectors today, including defense and security, artificial intelligence (AI), energy optimization, space and frontier, materials discovery, and cybersecurity.